Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease	Abnormalities, Multiple, Chronic Disease, Chronic Kidney Diseases, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, autosomal dominant polycystic kidney disease, chronic renal failure syndrome, cystic kidney disease, hereditary disease, kidney disorder, kidney failure, polycystic kidney disease, urinary system disorder	Enrolling by invitation	Phase 2	2023-05-23		NCT05870007

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Taipei Medical University Shuang Ho Hospital	22
University of Southern California	216

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shuang Ho Hospital	New Taipei City	Taiwan	2
Taipei Medical University Hospital	Taipei	Taiwan	19
Wan Fang Hospital	Taipei	Taiwan	4